Trial
NCT02790632
Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Edge Therapeutics Inc
Collaborators
—
Condition
Subarachnoid Hemorrhage, Aneurysmal
Intervention
EG-1962 (nimodipine microparticles)
Why stopped
DMC review concluded study has a low probability of meeting its primary endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-26